Rethinking the pharma R&D lifecycle with AI in mind
Drug Discovery World
AUGUST 7, 2024
In the last year alone, AI has been used for identifying novel targets 1 in areas like cardiomyopathy, generating novel antibodies 2 , and even designing newer modalities 3 like optimised mRNA vaccines for influenza. But the focus for AI can’t just be on discovery. To open source such intellectual property was previously unthinkable.
69 
Let's personalize your content